Hyperpolarization MRI preclinical models and potential applications in neuroradiology

Topics in Magnetic Resonance Imaging

Volumn 25, Issue 1, 2016, Pages 31-37

  Miloushev, Vesselin Z ^a   Keshari, Kayvan R ^a   Holodny, Andrei I ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

13c pyruvate; Brain tumor metabolism; Hyperpolarization mri; Preclinical models

Indexed keywords

2 OXOGLUTARIC ACID C 13; BICARBONATE C 13; FUMARIC ACID C 13; ISOCITRATE DEHYDROGENASE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PYRUVIC ACID C 13; UNCLASSIFIED DRUG; UREA C 13; RADIOPHARMACEUTICAL AGENT;

BRAIN TUMOR; DYNAMIC NUCLEAR POLARIZATION; HUMAN; HYPERPOLARIZATION; HYPERPOLARIZATION MAGNETIC RESONANCE IMAGING; MOLECULAR DIAGNOSIS; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR SPIN POLARIZATION; OXIDATION REDUCTION POTENTIAL; PARAHYDROGEN INDUCED POLARIZATION; PRIORITY JOURNAL; REVIEW; ANATOMY AND HISTOLOGY; BIOLOGICAL MODEL; BRAIN; COMPUTER ASSISTED DIAGNOSIS; COMPUTER SIMULATION; METABOLISM; MOLECULAR IMAGING; PROCEDURES;

BRAIN; COMPUTER SIMULATION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MODELS, NEUROLOGICAL; MOLECULAR IMAGING; RADIOPHARMACEUTICALS;

EID: 84959223174     PISSN: 08993459     EISSN: 15361004     Source Type: Journal    
DOI: 10.1097/RMR.0000000000000076     Document Type: Review

References (68)

1. Overhauser AW. Polarization of nuclei in metals. Phys Rev. 1953;92:411-415.
2. Ardenkjaer-Larsen JH, Fridlund B, Gram A, et al. Increase in signal-to-noise ratio of >10, 000 times in liquid-state NMR. Proc Natl Acad Sci U S A. 2003;100:10158-10163.
3. Bowers CR, Weitekamp DP. Transformation of symmetrization order to nuclear-spin magnetization by chemical reacion and nuclear-magneticresonance. Phys Rev Lett. 1986;57:2645-2648.
4. Bowers CR, Weitekamp DP. Parahydrogen and synthesis allow dramatically enhanced nuclear alignment. J Am Chem Soc. 1987;109:5541-5542.
5. Chekmenev EY, Hovener J, Norton VA, et al. PASADENA hyperpolarization of succinic acid for MRI and NMR spectroscopy. J Am Chem Soc. 2008;130:4212-4213.
6. Adams RW, Aguilar JA, Atkinson KD, et al. Reversible interactions with parahydrogen enhance NMR sensitivity by polarization transfer. Science. 2009;323:1708-1711.
7. Happer W, Miron E, Schaefer S, et al. Polarization of the nuclear spins of noble-gas atoms by spin exchange with optically pumped alkali-metal atoms. Phys Rev A. 1984;29:3092-3110.
8. Walker TG, Happer W. Spin-exchange optical pumping of noble-gas nuclei. Rev Modern Phys. 1997;69:629-642.
9. Carravetta M, Levitt MH. Theory of long-lived nuclear spin states in solution nuclear magnetic resonance. I. Singlet states in low magnetic field. J Chem Phys. 2005;122:214505.
10. Feng Y, Davis RM, Warren WS. Accessing long-lived nuclear singlet states between chemically equivalent spins without breaking symmetry. Nat Phys. 2012;8:831-837.
11. Stevanato G, Hill-Cousins JT, Hakansson P, et al. A nuclear singlet lifetime of more than one hour in room-temperature solution. Angew Chem Int Ed Engl. 2015;54:3740-3743.
12. Cunningham CH, Chen AP, Albers MJ, et al. Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C. J Magn Reson. 2007;187:357-362.
13. Larson PE, Kerr AB, Chen AP, et al. Multiband excitation pulses for hyperpolarized 13C dynamic chemical-shift imaging. J Magn Reson. 2008;194:121-127.
14. Yen YF, Kohler SJ, Chen AP, et al. Imaging considerations for in vivo 13C metabolic mapping using hyperpolarized 13C-pyruvate. Magn Reson Med. 2009;62:1-10.
15. Park I, Hu S, Bok R, et al. Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13C magnetic resonance spectroscopic imaging. Magn Reson Med. 2013;70:33-39.
16. Keshari KR, Wilson DM. Chemistry and biochemistry of 13C hyperpolarized magnetic resonance using dynamic nuclear polarization. Chem Soc Rev. 2014;43:1627-1659.
17. Mansson S, Johansson E, Magnusson P, et al. 13C imaging - A new diagnostic platform. Eur Radiol. 2006;16:57-67.
18. Bhattacharya P, Chekmenev EY, Perman WH, et al. Towards hyperpolarized (13)C-succinate imaging of brain cancer. J Magn Reson. 2007;186:150-155.
19. Zhang H. Hyperpolarized Sodium 1-[13C]Pyruvate. 2004. Bethesda, MD: National Center for Biotechnology Information (US); 2004-2013.
20. Psychogios N, Hau DD, Peng J, et al. The human serum metabolome. PLoS One. 2011;6:e16957.
21. Zilberter Y, Gubkina O, Ivanov AI. A unique array of neuroprotective effects of pyruvate in neuropathology. Front Neurosci. 2015;9:17.
22. Hertz L, Dienel GA. Lactate transport and transporters: general principles and functional roles in brain cells. J Neurosci Res. 2005;79:11-18.
23. Park JM, Josan S, Grafendorfer T, et al. Measuring mitochondrial metabolism in rat brain in vivo using MR spectroscopy of hyperpolarized [2- (1)(3)C]pyruvate. NMR Biomed. 2013;26:1197-1203.
24. Hurd RE, Yen YF, Mayer D, et al. Metabolic imaging in the anesthetized rat brain using hyperpolarized [1-13C] pyruvate and [1-13C] ethyl pyruvate. Magn Reson Med. 2010;63:1137-1143.
25. Mayer D, Yen YF, Takahashi A, et al. Dynamic and high-resolution metabolic imaging of hyperpolarized [1-13C]-pyruvate in the rat brain using a highperformance gradient insert. Magn Reson Med. 2011;65:1228-1233.
26. Park JM, Recht LD, Josan S, et al. Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized (13)C magnetic resonance spectroscopic imaging. Neuro Oncol. 2013;15:433-441.
27. Park I, Larson PE, Tropp JL, et al. Dynamic hyperpolarized carbon-13 MR metabolic imaging of nonhuman primate brain. Magn Reson Med. 2014;71:19-25.
28. Golman K, Zandt RI, Lerche M, et al. Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis. Cancer Res. 2006;66:10855-10860.
29. Nelson SJ, Kurhanewicz J, Vigneron DB, et al. Metabolic imaging of patients with prostate cancer using hyperpolarized [1-13C]pyruvate. Sci Transl Med. 2013;5:198ra108.
30. Hu S, Balakrishnan A, Bok RA, et al. 13C-pyruvate imaging reveals alterations in glycolysis that precede c-MYC induced tumor formation and regression. Cell Metab 2011; 14:131-142.
31. Warburg O. On the origin of cancer cells. Science. 1956;123:309-314.
32. Pelicano H, Martin DS, Xu RH, et al. Glycolysis inhibition for anticancer treatment. Oncogene. 2006;25:4633-4646.
33. Dang CV, Kim J-w, Gao P, et al. The interplay between MYC and HIF in cancer. Nat Rev Cancer. 2008;8:51-56.
34. Oudard S, Boitier E, Miccoli L, et al. Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure. Anticancer Res. 1997;17(3C):1903-1911.
35. DeBerardinis RJ, Mancuso A, Daikhin E, et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci. 2007;104:19345-19350.
36. Subhash MN, Rao BS, Shankar SK. Changes in lactate dehydrogenase isoenzyme pattern in patients with tumors of the central nervous system. Neurochem Int. 1993;22:121-124.
37. Chinnaiyan P, Kensicki E, Bloom G, et al. The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism. Cancer Res. 2012;72:5878-5888.
38. Vlashi E, Lagadec C, Vergnes L, et al. Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci U S A. 2011;108:16062-16067.
39. Park I, Larson PE, Zierhut ML, et al. Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. Neuro Oncol. 2010;12:133-144.
40. Park I, Bok R, Ozawa T, et al. Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging. J Magn Reson Imaging. 2011;33:1284-1290.
41. Park JM, Josan S, Jang T, et al. Metabolite kinetics in C6 rat glioma model using magnetic resonance spectroscopic imaging of hyperpolarized [1- 13C]pyruvate. Magn Reson Med. 2012;68:1886-1893.
42. Chaumeil MM, Ozawa T, Park I, et al. Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma. Neuroimage. 2012;59:193-201.
43. Dang L, White DW, Gross S, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462:739.
44. Choi C, Ganji SK, DeBerardinis RJ, et al. 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated glioma patients. Nat Med. 2012;18:624-629.
45. Andronesi OC, Kim GS, Gerstner E, et al. Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy. Sci Transl Med 2012; 4:116ra114.
46. Chaumeil MM, Larson PEZ, Yoshihara HAI, et al. Non-invasive in vivo assessment of IDH1 mutational status in glioma. Nat Commun. 2013;4:2429- 12429.
47. Chaumeil MM, Larson PE, Woods SM, et al. Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma. Cancer Res. 2014;74:4247-4257.
48. Kurhanewicz J, Vigneron DB, Brindle K, et al. Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia (New York NY). 2011;13:81-97.
49. Salamanca-Cardona L, Keshari KR. (13)C-labeled biochemical probes for the study of cancer metabolism with dynamic nuclear polarization-enhanced magnetic resonance imaging. Cancer Metab. 2015;3:9.
50. Gallagher FA, Kettunen MI, Hu DE, et al. Production of hyperpolarized [1, 4-13C2]malate from [1, 4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors. Proc Natl Acad Sci U S A. 2009;106: 19801-19806.
51. Cabella C, Karlsson M, Canape C, et al. In vivo and in vitro liver cancer metabolism observed with hyperpolarized [5-(13)C]glutamine. J Magn Reson. 2013;232:45-52.
52. Venneti S, Dunphy MP, Zhang H, et al. Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo. Sci Transl Med. 2015;7:274ra217.
53. Chesler M. Regulation and modulation of pH in the brain. Physiol Rev. 2003;83:1183-1221.
54. Gallagher FA, Kettunen MI, Day SE, et al. Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate. Nature. 2008;453:940-943.
55. Keshari KR, Sai V, Wang ZJ, et al. Hyperpolarized [1-(13)C]dehydroascorbate MR spectroscopy in a murine model of prostate cancer: comparison with (18)F-FDG PET. J Nucl Med. 2013;54:922-928.
56. Keshari KR, Kurhanewicz J, Bok R, et al. Hyperpolarized 13C dehydroascorbate as an endogenous redox sensor for in vivo metabolic imaging. Proc Natl Acad Sci U S A. 2011;108:18606-18611.
57. Lauritzen F, de Lanerolle NC, Lee TS, et al. Monocarboxylate transporter 1 is deficient on microvessels in the human epileptogenic hippocampus. Neurobiol Dis. 2011;41:577-584.
58. Lauritzen F, Heuser K, de Lanerolle NC, et al. Redistribution of monocarboxylate transporter 2 on the surface of astrocytes in the human epileptogenic hippocampus. Glia. 2012;60:1172-1181.
59. Wilson DM, Keshari KR, Larson PE, et al. Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities in vivo. J Magn Reson. 2010;205:141-147.
60. Harris RA, Tindale L, Cumming RC. Age-dependent metabolic dysregulation in cancer and Alzheimer's disease. Biogerontology. 2014;15:559-577.
61. Jiang T, Cadenas E. Astrocytic metabolic and inflammatory changes as a function of age. Aging Cell. 2014;13:1059-1067.
62. Mazzanti ML, Walvick RP, Zhou X, et al. Distribution of hyperpolarized xenon in the brain following sensory stimulation: preliminary MRI findings. PLoS One. 2011;6:e21607.
63. Pellerin L, Bouzier-Sore AK, Aubert A, et al. Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia. 2007;55:1251-1262.
64. Paulson OB, Hasselbalch SG, Rostrup E, et al. Cerebral blood flow response to functional activation. J Cereb Blood Flow Metab. 2010;30:2-14.
65. Belanger M, Allaman I, Magistretti PJ. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 2011;14:724-738.
66. Turner DA, Adamson DC. Neuronal-astrocyte metabolic interactions: understanding the transition into abnormal astrocytoma metabolism. J Neuropathol Exp Neurol. 2011;70:167-176.
67. Park JM, Josan S, Jang T, et al. Volumetric spiral chemical shift imaging of hyperpolarized [2- c]pyruvate in a rat c6 glioma model. Magn Reson Med;. 2015 [Epub ahead of print].
68. Golman K, Ardenkjaer-Larsen JH, Petersson JS, et al. Molecular imaging with endogenous substances. Proc Natl Acad Sci U S A. 2003;100:10435-10439.